Position in SYRE
as of Jun 30, 2026
· filed Sep 2, 2026
Position Value
$9,153,217
+$3,698,888 QoQ
Shares Held
103,100
-4.7% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#76
of 266 holders
Holding Since
Sep 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SYRE Over Time
Shares Held
Position Value (USD)
Derivatives in SYRE
reported options exposure · as of Jun 30, 2026CallValue
$3,888,564
CallShares
43,800
PutValue
$701,362
PutShares
7,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. SYRE ranks #102 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in SYRE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $701,362 | 7,900 | Put | Defined | 2026-09-02 | |
| 2026-06-30 | $3,888,564 | 43,800 | Call | Defined | 2026-09-02 | |
| 2026-06-30 | $9,153,217 | 103,100 | Shares | Defined | 2026-09-02 | |
| 2026-03-31 | $771,732 | 15,300 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $5,454,329 | 108,135 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,093,495 | 63,904 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $815,724 | 24,900 | Put | Defined | 2026-02-17 | |
| 2025-03-31 | $98,423 | 6,100 | Put | Defined | 2025-05-15 | |
| 2025-03-31 | $51,632 | 3,200 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $2,111,812 | 130,884 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $79,152 | 3,400 | Put | Defined | 2025-02-14 | |
| 2024-12-31 | $160,632 | 6,900 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $25,126,266 | 1,079,307 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $17,646 | 600 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $20,810,104 | 707,586 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $38,233 | 1,300 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $35,265 | 1,500 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $61,126 | 2,600 | Call | Defined | 2024-08-14 | |
| 2024-06-30 | $16,635,346 | 707,586 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $26,838,887 | 707,590 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $12,410,820 | 576,711 | Shares | Defined | 2024-02-14 | |
| 2023-12-31 | $1,291 | 60 | Call | Defined | 2024-02-14 | |
| 2023-12-31 | $86 | 4 | Put | Defined | 2024-02-14 | |
| 2023-09-30 | $686 | 56 | Call | Defined | 2023-11-14 | |
| 2023-09-30 | $49 | 4 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $1,188,899 | 97,053 | Shares | Defined | 2023-11-14 | |
| No filing history on record for this holder in this stock. | ||||||